Product Name:
Tirz 30 (Tirzepatide 30mg)
Chemical Information:
- Molecular Formula: C225H348N48O68
- Molecular Weight: ~4813.45 g/mol
- Sequence: Proprietary sequence mimicking dual GIP/GLP-1 activity
- Structure: Lyophilized peptide powder
Description:
Tirz 30 features Tirzepatide, a cutting-edge dual-agonist peptide that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Preclinical studies suggest this dual mechanism offers enhanced metabolic effects over traditional single-agonist treatments, including reduced appetite, improved insulin sensitivity, and accelerated fat metabolism.
This research-grade compound is supplied in lyophilized form to ensure long-term preservation and bioactivity.
Research Applications:
Tirz 30 is being studied in various research contexts, including:
- Obesity & Weight Management: Enhancing satiety signals and reducing caloric intake.
- Type 2 Diabetes Studies: Improving insulin secretion and reducing fasting glucose levels.
- Lipid Regulation: Investigating the impact on triglycerides and cholesterol profiles.
- Dual-Receptor Synergy: Exploring combined effects on glucose metabolism and fat oxidation.
Storage and Handling:
- Store at –20°C in a sealed, dry environment.
- Reconstitute at 2–8°C using bacteriostatic water.
- Minimize exposure to light and repeated freeze-thaw cycles.
- Follow all lab safety procedures during handling.
Product Specifications:
- Purity: ≥98% (HPLC Verified)
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in bacteriostatic water
Important Note:
TIRZ 30 IS FOR RESEARCH USE ONLY.
Not intended for human or veterinary consumption. Any misuse may violate local, state, or federal regulations.
Reviews
There are no reviews yet.